These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8503021)

  • 1. Use of biological markers in the diagnosis of cancers of unknown primary tumor.
    Ruddon RW; Norton SE
    Semin Oncol; 1993 Jun; 20(3):251-60. PubMed ID: 8503021
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour markers in cancers of unknown primary: a clinical perspective.
    Savage P
    Ann Clin Biochem; 2006 Jan; 43(Pt 1):1-2. PubMed ID: 16390602
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum tumor markers in the diagnosis of cancer of unknown primary site].
    Cohen AD; Neuman A; Cohen Y
    Harefuah; 1995 Oct; 129(7-8):279-82. PubMed ID: 8549972
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene expression profiling in cancers of unknown primary.
    Varadhachary GR; Raber MN
    J Clin Oncol; 2009 Sep; 27(25):e85-6; author reply e87-8. PubMed ID: 19635993
    [No Abstract]   [Full Text] [Related]  

  • 5. [The CUP syndrome--malignant disease with unknown primary tumor. Part 3: Metastatic site--tumor markers].
    Jaspersen D
    Fortschr Med; 1992 Nov; 110(30):562-4. PubMed ID: 1468742
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic and prognostic yield of tumor markers in cancer of unknown primary site.
    Parvez T; Ibraheim MI
    J Coll Physicians Surg Pak; 2006 Feb; 16(2):154-6. PubMed ID: 16499817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancers of unknown primary site: an enigmatic syndrome.
    Anand AC; Singh B
    Trop Gastroenterol; 1988; 9(2):57-67. PubMed ID: 3051600
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnostic strategies for unknown primary cancer.
    Varadhachary GR; Abbruzzese JL; Lenzi R
    Cancer; 2004 May; 100(9):1776-85. PubMed ID: 15112256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying the primary site using gene expression profiling in patients with carcinoma of an unknown primary (CUP): a feasibility study from the GEFCAPI.
    Gross-Goupil M; Massard C; Lesimple T; Merrouche Y; Blot E; Loriot Y; Mathieu MC; Fizazi K
    Onkologie; 2012; 35(1-2):54-5. PubMed ID: 22310348
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene expression array analysis to determine tissue of origin of carcinoma of unknown primary: cutting edge or already obsolete?
    Dolled-Filhart MP; Rimm DL
    Cancer Cytopathol; 2013 Mar; 121(3):129-35. PubMed ID: 22927160
    [No Abstract]   [Full Text] [Related]  

  • 11. [Unknown primary tumour--diagnostic strategies and treatment].
    Møller AK; Gundgaard MG; Petersen BL; Daugaard G
    Ugeskr Laeger; 2008 Nov; 170(48):3946-9. PubMed ID: 19087733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential diagnosis in immunohistochemistry with Bayes theorem.
    Vollmer RT
    Am J Clin Pathol; 2009 May; 131(5):723-30. PubMed ID: 19369634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm.
    Dennis JL; Hvidsten TR; Wit EC; Komorowski J; Bell AK; Downie I; Mooney J; Verbeke C; Bellamy C; Keith WN; Oien KA
    Clin Cancer Res; 2005 May; 11(10):3766-72. PubMed ID: 15897574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case with widespread cutaneous metastases of unknown primary origin: grave prognostic finding in cancer.
    Koca R; Ustundag Y; Kargi E; Numanoglu G; Altinyazar HC
    Dermatol Online J; 2005 Mar; 11(1):16. PubMed ID: 15748557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemical identification of carcinomas of unknown primary in serous effusions.
    Pomjanski N; Grote HJ; Doganay P; Schmiemann V; Buckstegge B; Böcking A
    Diagn Cytopathol; 2005 Nov; 33(5):309-15. PubMed ID: 16240395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical diagnosis of primary unknown cancer-the present situation and problems].
    Mukai H
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):915-7. PubMed ID: 19542711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of L1-CAM immunohistochemial staining in the diagnosis of abdominal-pelvic cancer of uncertain primary site in women.
    Ben-Arie A; Huszar M; Ben-Zvi N; Smirnov A; Altevogt P; Fogel M
    Eur J Surg Oncol; 2008 Jul; 34(7):795-9. PubMed ID: 17845837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in unknown primary cancer.
    Culine S
    Semin Oncol; 2009 Feb; 36(1):60-4. PubMed ID: 19179189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological evaluation of neoplasms with unknown primary tumor site.
    Mackay B; Ordonez NG
    Semin Oncol; 1993 Jun; 20(3):206-28. PubMed ID: 8503017
    [No Abstract]   [Full Text] [Related]  

  • 20. Idiopathic versus secondary thrombosis as a predictive marker of occult malignancy.
    Girolami A
    Thromb Haemost; 1998 Jul; 80(1):206-7. PubMed ID: 9684816
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.